GlassScriptPhysician profile
Shaan Sudhakaran
NPI 1598101859
$3,328.96
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,337 · 2020: $443 · 2021: $500 · 2022: $49.64.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,298.09 | 2019-2020 | |
| Abbott Laboratories | $697.71 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $187.57 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $166.51 | 2019-2021 | |
| Boston Scientific Corporation | $145.27 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $132.01 | 2020-2022 | |
| Horizon Therapeutics Plc | $122.30 | 2019-2021 | |
| Stimwave Technologies Incorporated | $100.62 | 2021 | |
| Pfizer INC. | $90.21 | 2019-2021 | |
| Pacira Therapeutics, INC. | $59.20 | 2019 | |
| Vertical Pharmaceuticals, LLC | $49.16 | 2019 | |
| Fidia Pharma USA INC. | $46.92 | 2019-2022 | |
| Allergan, INC. | $42.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.51 | 2019 | |
| Almatica Pharma LLC | $27.99 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $26.90 | 2019 | |
| Daiichi Sankyo INC. | $24.48 | 2019 | |
| Bioventus LLC | $19.23 | 2019 | |
| Vertos Medical, INC. | $17.46 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.99 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.64 | 2022 | |
| Kaleo, INC. | $13.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaan Sudhakaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.